India · Delayed Price · Currency is INR Max Healthcare Institute Statistics
Total Valuation
NSE:MAXHEALTH has a market cap or net worth of INR 901.29 billion. The enterprise value is 935.54 billion.
| Market Cap | 901.29B |
| Enterprise Value | 935.54B |
Important Dates
The last earnings date was Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Jul 3, 2026 |
Share Statistics
| Current Share Class | 973.31M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.06% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 23.73% |
| Owned by Institutions (%) | 51.87% |
| Float | 699.44M |
Valuation Ratios
The trailing PE ratio is 65.62 and the forward PE ratio is 43.98.
| PE Ratio | 65.62 |
| Forward PE | 43.98 |
| PS Ratio | 9.85 |
| PB Ratio | 7.81 |
| P/TBV Ratio | 17.55 |
| P/FCF Ratio | 151.27 |
| P/OCF Ratio | 49.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 38.20, with an EV/FCF ratio of 157.02.
| EV / Earnings | 67.76 |
| EV / Sales | 10.23 |
| EV / EBITDA | 38.20 |
| EV / EBIT | 47.88 |
| EV / FCF | 157.02 |
Financial Position
The company has a current ratio of 0.84, with a Debt / Equity ratio of 0.33.
| Current Ratio | 0.84 |
| Quick Ratio | 0.73 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 1.55 |
| Debt / FCF | 6.37 |
| Interest Coverage | 7.78 |
Financial Efficiency
Return on equity (ROE) is 12.79% and return on invested capital (ROIC) is 10.55%.
| Return on Equity (ROE) | 12.79% |
| Return on Assets (ROA) | 6.98% |
| Return on Invested Capital (ROIC) | 10.55% |
| Return on Capital Employed (ROCE) | 12.04% |
| Weighted Average Cost of Capital (WACC) | 4.81% |
| Revenue Per Employee | 6.05M |
| Profits Per Employee | 913,438 |
| Employee Count | 15,114 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 27.43 |
Taxes
In the past 12 months, NSE:MAXHEALTH has paid 4.26 billion in taxes.
| Income Tax | 4.26B |
| Effective Tax Rate | 23.57% |
Stock Price Statistics
The stock price has decreased by -19.09% in the last 52 weeks. The beta is 0.10, so NSE:MAXHEALTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -19.09% |
| 50-Day Moving Average | 947.79 |
| 200-Day Moving Average | 1,012.01 |
| Relative Strength Index (RSI) | 59.62 |
| Average Volume (20 Days) | 3,963,572 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MAXHEALTH had revenue of INR 91.46 billion and earned 13.81 billion in profits. Earnings per share was 14.13.
| Revenue | 91.46B |
| Gross Profit | 57.69B |
| Operating Income | 19.54B |
| Pretax Income | 18.06B |
| Net Income | 13.81B |
| EBITDA | 23.91B |
| EBIT | 19.54B |
| Earnings Per Share (EPS) | 14.13 |
Balance Sheet
The company has 5.71 billion in cash and 37.95 billion in debt, with a net cash position of -32.24 billion.
| Cash & Cash Equivalents | 5.71B |
| Total Debt | 37.95B |
| Net Cash | -32.24B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 115.33B |
| Book Value Per Share | 116.34 |
| Working Capital | -3.97B |
Cash Flow
In the last 12 months, operating cash flow was 18.31 billion and capital expenditures -12.35 billion, giving a free cash flow of 5.96 billion.
| Operating Cash Flow | 18.31B |
| Capital Expenditures | -12.35B |
| Depreciation & Amortization | 4.37B |
| Net Borrowing | 3.76B |
| Free Cash Flow | 5.96B |
| FCF Per Share | n/a |
Margins
Gross margin is 63.08%, with operating and profit margins of 21.36% and 15.10%.
| Gross Margin | 63.08% |
| Operating Margin | 21.36% |
| Pretax Margin | 19.75% |
| Profit Margin | 15.10% |
| EBITDA Margin | 26.14% |
| EBIT Margin | 21.36% |
| FCF Margin | 6.51% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.22%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 0.22% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 14.08% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.06% |
| Shareholder Yield | 0.27% |
| Earnings Yield | 1.52% |
| FCF Yield | 0.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:MAXHEALTH is 1,139.85, which is 22.94% higher than the current price. The consensus rating is "Buy".
| Price Target | 1,139.85 |
| Price Target Difference | 22.94% |
| Analyst Consensus | Buy |
| Analyst Count | 28 |
| Revenue Growth Forecast (3Y) | 25.59% |
| EPS Growth Forecast (3Y) | 23.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |